Table 2.
Blood biochemical parameters | T0 First Trial | T0 Second Trial | Normal values |
---|---|---|---|
Chlorine (Cl) mmol/l | 101.2 ± 3.9 | 109.5 ± 8.8 | 105–115 |
Ferro (Fe) μmol/l | 24.9 ± 7.6 | 26.7 ± 9.2 | 15–40 |
Phosphorus (P) mmol/l | 1.0 ± 0.19 | 1.37 ± 0.16 | 0.84–2 |
Glutamic Oxaloacetic Transaminase (GOT) U/l | 24.5 ± 3.5 | 24.0 ± 5.7 | 23–44 |
Glutamic Pyruvic Transaminase (GPT) U/l | 35.1 ± 11.1 | 37.0 ± 13.8 | 10–50 |
Alkaline Phosphatase (ALP) U/l | 45.2 ± 3.2 | 37.6 ± 3.2 | 20–120 |
Glucose (mmol/l) | 3.9 ± 0.4 | 5.5 ± 0.7 | 3.61–6.55 |
Lactate dehydrogenase (LDH) | 174.7 ± 55.0 | 63.3 ± 10.6 | 45–233 |
Non-Esterified Fatty Acids (NEFA) mmol/l | 0.44 ± 0.05 | 0.34 ± 0.05 | 0.4–0.7 |
Creatine Kinase (CK) U/l | 80.3 ± 23.0 | 118.2 ± 34.3 | 30–120 |
Creatinine μmol/l | 116.4 ± 15.5 | 104.5 ± 15.6 | 44.2–132.6 |
Averages ± standard deviations of blood parameters evaluated in the dogs at T0 (24 hours before T1) First Trial (U and EE) and T0 Second Trial (EE and EEplus).